Beam Therapeutics BEAM
NASDAQ BEAM
$25.15 -1.87 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Shares Outstanding (2019 - 2026)

Updated

Beam Therapeutics' Weighted Average Shares Outstanding came in at 104.7 million for Q3 2026, up 2.1% from 102.57 million a year earlier and up 0.4% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Shares Outstanding (2019 - 2026) Analysis & Trends

For FY2025, Beam Therapeutics' Weighted Average Shares Outstanding was 98.91 million, up 20.2% from FY2024.

  • Weighted Average Shares Outstanding has increased in each of the last six years, with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding was 82.31 million in FY2024 (+6.7%), 77.15 million in FY2023 (+10.2%), 70.02 million in FY2022 (+9.0%) and 64.23 million in FY2021 (+37.4%).
  • The Q3 2026 figure represents the highest quarterly Weighted Average Shares Outstanding in data going back to Q1 2019.
  • Year-over-year, Weighted Average Shares Outstanding has increased for 27 consecutive quarters, with growth averaging 13.1% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding has ranged between 2.1% (Q3 2026) and 37.4% (Q4 2021) over the last five years.
  • Business Quant data shows BEAM's Weighted Average Shares Outstanding at 104.33 million (Q2 2026), 103.26 million (Q1 2026) and 98.91 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 2.41 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 1.77 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.94 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.55 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.24 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.70 Bn
10 Beam Therapeutics 2.73 Bn -1.93 Bn - 104.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 104.70 Mn
Jun 30, 2026 104.33 Mn
Mar 31, 2026 103.26 Mn
Dec 31, 2025 98.91 Mn
Sep 30, 2025 102.57 Mn
Jun 30, 2025 102.00 Mn
Mar 31, 2025 87.98 Mn
Dec 31, 2024 82.31 Mn
Sep 30, 2024 82.41 Mn
Jun 30, 2024 82.31 Mn
Mar 31, 2024 81.70 Mn
Dec 31, 2023 77.15 Mn
Sep 30, 2023 79.02 Mn
Jun 30, 2023 76.34 Mn
Mar 31, 2023 72.27 Mn
Dec 31, 2022 70.02 Mn
Sep 30, 2022 70.34 Mn
Jun 30, 2022 70.21 Mn
Mar 31, 2022 68.70 Mn
Dec 31, 2021 64.23 Mn
API Access

Beam Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=BEAM&period=max&api_key=YOUR_API_KEY